家兔低密度脂蛋白胆固醇增高及同步饮磁处理水时动脉内膜病理学变化的比较研究

目的:观察家兔实验性低密度脂蛋白胆固醇(LDL -c)增高及同步饮磁处理水时动脉内膜病理变化的区别,探讨磁处理水对动脉粥样硬化的预防作用。方法:新西兰雄性大白兔随机分为3组即对照组(NG)、模型组(ASG)和预防组(MWG) ,以高脂饲料复制家兔动脉粥样硬化(AS)模型。MWG家兔喂高脂饲料同步饮磁处理水,分阶段检测各组家兔血浆LDL -c含量并观察其主动脉内膜病理学改变。结果:MWG血浆LDL -c含量明显较ASG降低(P <0 .0 1,MWG主动脉内膜脂质沉积及粥样斑块形成面积较ASG减小(P <0 .0 1,内膜增生程度较ASG减轻(P <0 .0 1)。结论:提示磁处理水在家兔实验性高LDL -c血症及AS的预防中起一定作用。     

磁处理党参药液对小鼠血液生理功能影响的研究

目的:观察小白鼠饮食磁处理党参药液后对血液功能的影响。方法:用血球计数仪测定白细胞数(WBC)、红细胞数(RBC)、血红蛋白浓度(HGB)及血小板数(PLT) ,采用比较法比较正常对照组、非磁处理党参药液组与磁处理党参药液组对小白鼠血液功能的影响。结果:与正常对照组比较,磁处理党参药液组白细胞数差异不显著(p >0 .0 5 ) ,红细胞数、血红蛋白浓度显著提高,差异极显著(p <0 .0 1) ,血小板数0 .2 5T药液组达差异显著(p <0 .0 5 ) ,0 .1T药液组差异不显著;与非磁处理药液组比较,磁处理党参药液组白细胞数差异不显著(p >0 .0 5 ) ,而红细胞数、血红蛋白浓度及0 .2 5T血小板数均有提高,差异极显著(p <0 .0 1) ,0 .1T药液组血小板数差异不显著(p >0 .0 5 )。结论:磁处理党参药液对血细胞数变化有明显作用。     

磁处理党参、白术药液对胃蛋白酶活性影响的研究

目的 :观察磁处理党参、白术药液对胃蛋白酶活性的影响。方法 :用麦特 (Mett)氏法比较正常对照组 ,非磁处理党参、白术药液组与磁处理党参、白术药液组的胃蛋白酶活性。结果 :与正常对照组比较 ,磁处理党参、白术药液组有显著提高胃蛋白酶活性的作用 (p <0 .0 1 ) ;与非磁处理药液组比较 ,磁处理药液组也都有提高胃蛋白酶活性的作用 (p <0 .0 5及p <0 .0 1 )。结论 :磁处理党参、白术药液可提高胃蛋白酶活性     

磁处理党参药液对小白鼠碳粒廓清功能影响的研究

目的 :观察小白鼠饮用磁处理党参药液后对碳粒廓清功能的影响。方法 :用碳粒廓清法比较正常对照组、非磁处理党参药液组与磁处理党参药液组对小白鼠碳粒廓清功能的影响。结果 :与正常对照组比较 ,磁处理党参药液组光密度 (OD)降低 ,差异极显著 (p <0 .0 1 ) ,廓清指数 (K)都有提高 ,差异显著 (p <0 .0 5 ) ,吞噬指数 (α)也有提高 ,其中 0 .2 5T药液组达差异显著 (p <0 .0 5 ) ;与非磁处理药液组比较 ,光密度(OD)逐渐下降 ,当取血时间为 1 0min时 ,0 .2 5T药液组达差异显著 (p <0 .0 5 ) ,廓清指数 (K) ,0 .2 5T药液组有提高 ,但差异不显著 ,吞噬指数 (α)都有提高 ,仅 0 .2 5T药液组达差异显著 (p <0 .0 5 )。结论 :磁处理党参药液具有促进单核巨噬细胞系统吞噬功能的作用 ,对免疫有良好作用。     

磁处理党参药液对小鼠肠推进运动影响的药效研究

目的 :观察磁处理党参药液对小鼠肠推进运动的影响。方法 :实验分为非磁处理党参药液对照组 ,生理盐水对照组 ,0 .1T磁处理试验组和 0 .2 5T磁处理药液试验组 ,采用灌胃给药的途径进行实验观察。结果 :0 .1T和 0 .2 5T磁处理药液组和生理盐水对照组相比较 ,试验组具有显著促进小鼠肠的炭末推进作用 (p <0 .0 1 ) ;非磁处理与磁处理党参药液组相比较 ,0 .1T和 0 .2 5T磁处理药液组对小肠的炭末推进率有着显著的抑制作用 (p <0 .0 1 )。结论 :党参磁处理药液对小鼠肠的推进有明显作用。     

旋磁场对健康人和矽肺病人血清铜蓝蛋白活力的影响

目的 :为了解旋磁场对健康人、矽肺患者血清铜蓝蛋白 (Cp)活力的影响。方法 :Cp采用联大茴香胺法进行测定。结果 :在旋磁场中曝磁 30分钟后 ,健康曝磁组血清Cp( 1 0 1 .1 2± 39.35 )与健康对照组血清Cp( 73.0 9± 36.72 )相比活力显著增加 (p <0 .0 5 ) ;矽肺曝磁组血清Cp( 1 63.36± 32 .64)与矽肺对照组血清Cp( 1 2 3.80± 2 8.2 5 )相比活力显著增加 (p <0 .0 1 )。结论 :旋磁场影响健康人和矽肺患者血清铜蓝蛋白的活力。     

磁处理水对家兔生殖影响的研究

目的:探讨磁处理水对家免睾丸、附睾重量以及精子活力、沃纱、密度的影响。方法:新西兰雄性大白免36只,随机分为实验组和对照组。对照组饮用自来水,实验组饮用磁处理水,磁处理水每天更换,实验进行90天。光镜下检测每只家免附睾尾精子密度,精子活力,精子活率,最后将睾丸、附睾称重。结果:实验组与对照组比较,其睾丸附睾重量明显增加,精子密度增加14 % ,精子活力增加8% ,精子活率增加11% ,两组差异有显著性(P <0 .0 5 )。结论:实验结果提示饮用磁处理水能显著提高家免的生殖能力。     

磁场处理离体小肠对葡萄糖吸收功能的影响

目的 :观察磁场处理离体小肠对葡萄糖吸收功能的影响。方法 :用经 0 .1T和 0 .2 5T磁场处理小白鼠离体小肠 ,分别测定其对葡萄糖的吸收值。结果 :用 0 .1T和 0 .2 5T磁场处理的小白鼠离体小肠浆膜侧吸收葡萄糖的量与对照组比较 ,0 .1T差异显著 (p <0 .0 5 ) ,0 .2 5T的差异极显著 (p <0 .0 1 )。结论 :用0 .1T和 0 .2 5T磁场处理的小白鼠离体小肠对葡萄糖的吸收均有明显的促进作用。     

阿司匹林增加胰岛素抵抗大鼠胰岛素敏感性的实验研究

目的　观察阿司匹林对高脂饮食大鼠胰岛素敏感性的影响。方法　灌服阿司匹林前后采用腹腔注射胰岛素耐量试验 (IITT)观察大鼠胰岛素的敏感性 ,并测定空服胰岛素、血糖和血脂等。结果　高脂饮食 4月、阿司匹林治疗 4周后 ,IITT发现高脂组腹腔注射胰岛素后 1h、1 5h和 2h的血糖及空腹胰岛素和甘油三酯水平显著高于正常对照组 (P <0 0 5或P <0 0 1 ) ;而阿司匹林治疗组腹腔注射胰岛素后 1h、1 5h和 2h的血糖及空腹胰岛素和甘油三酯水平显著低于高脂组 (P <0 0 5或P <0 0 1 ) ,与正常对照组差异无显著性。结论　大剂量阿司匹林有增加胰岛素敏感性和改善脂代谢紊乱的作用     

磁处理白术药液对小白鼠免疫器官指数影响的药效研究

目的 :从免疫学方面探讨磁处理白术药液对小白鼠免疫器官指数影响的药效作用。方法 :用不同强度的磁处理白术药液及非磁处理白术药液对小白鼠进行腹腔注射 ,连续 7d ,每天一次 ,末次给药 1 2h后处死 ,称其体重 ,取出胸腺、脾脏及肝脏 ,称重 ,计算各器官指数。结果 :与正常对照组比较 ,磁处理白术药液组对小白鼠的肝脏指数、脾脏指数均有极显著的提高 (P <0 .0 1 ) ,胸腺指数也有影响 ,但差异不显著 (P>0 .0 5 ) ;与非磁处理药液组比较 ,磁处理药液组对小白鼠的肝脏指数、脾脏指数、胸腺指数有影响 ,但差异不显著 (P >0 .0 5 )。结论 :磁处理白术药液对免疫器官指数有明显作用     

人血浆HDL对动脉粥样硬化家兔肝细胞膜 LDL受体活性影响的研究

高胆固醇饲料喂养造成的动脉粥样硬化（Ａｓ） 模型家兔通过静脉注射人血浆ＨＤＬ 制剂, 观察ＨＤＬ 对Ａｓ家兔肝细胞膜ＬＤＬ受体活性的影响． 结果发现, 摄取高胆固醇饲料的Ａｓ 家兔, 其肝细胞膜ＬＤＬ 受体 Ｋｄ 值虽无明显变化但Ｂｍａｘ 值显著减小（ Ｐ＜ ０－０１ , 与正常对照组比较） ; 注射ＨＤＬ 制剂后, Ａｓ 家兔肝细胞膜ＬＤＬ受体Ｋｄ 值仍无明显改变, 但Ｂｍａｘ 值却显著回升（ Ｐ＜ ０－０１ , 与高脂组比较） ． 表明人血浆ＨＤＬ 具有增加Ａｓ 家兔肝细胞膜ＬＤＬ 受体活性的作用．     

Transgenic rabbits as models for atherosclerosis research

Several characteristics of the rabbit make it an excellent model for the study of lipoprotein metabolism and atherosclerosis. New Zealand White (NZW) rabbits have low plasma total cholesterol concentrations, high cholesteryl ester transfer protein activity, low hepatic lipase (HL) activity, and lack an analogue of human apolipoprotein (apo) A-II, providing a unique system in which to assess the effects of human transgenes on plasma lipoproteins and atherosclerosis susceptibility. Additionally, rabbit models of human lipoprotein disorders, such as the Watanabe Heritable Hyperlipidemic (WHHL) and St. Thomas' Hospital strains, models of familial hypercholesterolemia and familial combined hyperlipidemia, respectively, allow for the assessment of candidate genes for potential use in the treatment of dyslipoproteinemic patients. To date, transgenes for human apo(a), apoA-I, apoB, apoE2, apoE3, HL, and lecithin:cholesterol acyltransferase (LCAT), as well as for rabbit apolipoprotein B mRNA-editing enzyme catalytic poly-peptide 1 (APOBEC-1), have been expressed in NZW rabbits, whereas only those for human apoA-I and LCAT have been introduced into the WHHL background. All of these transgenes have been shown to have significant effects on plasma lipoprotein concentrations. In both NZW and WHHL rabbits, human apoA-I expression was associated with a significant reduction in the extent of aortic atherosclerosis, which was similarly the case for LCAT in rabbits having at least one functional LDL receptor allele. Conversely, expression of apoE2 in NZW rabbits caused increased susceptibility to atherosclerosis. These studies provide new insights into the mechanisms responsible for the development of atherosclerosis, emphasizing the strength of the rabbit model in cardiovascular disease research.     

Comparison of the lipoprotein profiles obtained from rat, bovine, horse, dog, rabbit and pig serum by a new two-step ultracentrifugal gradient procedure

A new two-step gradient technique has been used in the separation of the different classes of lipoproteins from the serum of cows, horses, dogs, pigs, rabbits and rats. Total lipoproteins were first isolated at d 1.21 then floated through a d 1.006 to d 1.21 gradient. Collection by mean of a gradient fractionator provided directly comparable lipoprotein profiles, allowed the determination of the exact density range of each lipoprotein class and the fraction by fraction analysis of composition. Cholesterol and apo AI recoveries were high. Horse, dog, rabbit and pig exhibited three distinct lipoprotein classes: VLDL, LDL and HDL. LDL were polydisperse in the pig (three components), light in the rabbit and scarce in the horse. In the Sprague-Dawley rat, LDL could not be individualized from HDL. In the bovine, LDL overlapped with a light form of HDL. Although AI was the main apoprotein in the HDL of all species, it ranged in proportion from 35% in the rat to 75% in the bovine. Apo AII was dimeric in the dog, as already known, but also in the horse, rabbit and bovine (MW:17,000) and in the pig MW:13,000). Apo AIV was present in the heavier HDL of all species. Rabbit, horse and pig HDL contained only one species of apo C which, in the pig was identified as apo CII.     

不同浓度下的中药复方对四川白兔生长的影响

本次研究旨在探讨中药复方对四川白兔生长性能、免疫功能及其抗氧化情况的作用。采用单因子实验设计,选择30日龄断奶四川白兔仔兔100只,随机分为5组(每组20只,雌雄各半),试验3组为高浓度组(基础日粮+3%中药添加剂),试验2组为中等浓度组(基础日粮+2%中药添加剂),试验1组为低浓度组(基础日粮+1%中药添加剂),试验4组为阳性组(基础日粮+1%杆菌肽锌+1%硫酸黏杆菌素),对照组饲喂基础日粮。试验期为56 d,其中预试期为7 d,正试期为49 d。正试期内测定试兔的生长性能,试验结束时测定试兔的抗氧化和免疫指标。结果显示:高浓度组显著提高了兔的Ig M (p<0.05),中等浓度组极显著提高了兔的Ig A (p<0.01),且死亡率均为0;低浓度组和高浓度组显著提高了兔丙二醛(MDA)或超氧化物歧化酶(SOD)的活性;低浓度组显著提高了兔的脾指数(p<0.05);高浓度组显著提高或降低了兔十二指肠的绒毛高度或隐窝深度(p<0.05);中等浓度组显著提高了回肠的绒毛高度(p<0.0.5)。饲粮添加一定的中药复方不仅能改善兔子的生长性能,增强四川白兔的免疫能力及抗氧化性,也可以降低四川白兔死亡发生概率。     

The Transgenic Rabbit as Model for Human Diseases and as a Source of Biologically Active Recombinant Proteins

Until recently, transgenic rabbits were produced exclusively by pronuclear microinjection which results in additive random insertional transgenesis; however, progress in somatic cell cloning based on nuclear transfer will soon make it possible to produce rabbits with modifications to specific genes by the combination of homologous recombination and subsequent prescreening of nuclear donor cells. Transgenic rabbits have been found to be excellent animal models for inherited and acquired human diseases including hypertrophic cardiomyopathy, perturbed lipoprotein metabolism and atherosclerosis. Transgenic rabbits have also proved to be suitable bioreactors for the production of recombinant protein both on an experimental and a commercial scale. This review summarizes recent research based on the transgenic rabbit model.     

Development and partial metabolic characterization of a dietary cholesterol-resistant colony of rabbits

A colony of New Zealand white rabbits has been developed which, when fed a cholesterol-supplemented diet, exhibit unusual resistance to hypercholesterolemia and atherosclerosis, disorders usually observed in normal cholesterol-fed rabbits. When resistant rabbits (RT) were fed a normal low cholesterol diet (ND), their plasma lipoprotein patterns were significantly different from those of normal rabbits (NR) fed the same diet. The low density lipoprotein cholesterol (LDL-c)/high density lipoprotein cholesterol (HDL-c) ratio and LDL-c/very low density lipoprotein cholesterol (VLDL-c) ratio were lower in the resistant rabbits. The hydrated density of HDL of the normal-responsive rabbits was greater than that of the resistant rabbits. LDL from resistant rabbits contained a lower proportion of esterified cholesterol and protein than LDL from normal rabbits. Peripheral mononuclear cells from resistant rabbits bound about 30% more 125I-labeled rabbit LDL than mononuclear cells from normal rabbits. These results demonstrate that the plasma cholesterol levels of these animals is at least partly under genetic control and that compositional differences exist between the major plasma lipoprotein classes of normal and resistant rabbits even during the ingestion of low-cholesterol diet. The results indicate that at least a part of the difference in the cholesterolemic responses between the two rabbit groups is due to an enhanced LDL uptake by the mononuclear cells, and presumably by other somatic cells of the resistant group.     

兔实验性肝性脑病1H磁共振波谱初步研究

目的:研究兔实验性肝性脑病1H磁共振波谱(magnetic resonance spectroscopy,MRS)变化。方法:将24只兔子随机分三组:对照组,肝硬化组,肝性脑病组,各8只。肝性脑病组采用四氯化碳(CCl4)联合内毒素方法制作肝性脑病兔子模型,肝硬化组采用CCl4制作肝硬化模型。分别在第4、6、8、10、12周取肝脏病理活检,第12周测量血氨值,并进行兔子脑组织的MRS扫描。计算N-乙酰天门冬氨酸(N-acetyl asparte,NAA)、肌酸(creatine,Cr)、胆碱(choline,Cho)、肌醇(myo-inositol,mI)和谷氨酰胺复合物(glutamine and glutamate,Glx)的峰下面积,计算NAA/Cr、Cho/Cr、mI/Cr、Glx/Cr。结果:与对照组及肝硬化组相比,肝性脑病组兔血氨上升,脑部MRS显示Glx/Cr升高,Cho/Cr降低,差异显著(P0.05)。与对照组相比,肝硬化组血氨以及MRS改变无统计学意义。结论:兔实验性肝性脑病1H磁共振波谱存在变化。     

The rabbit as an animal model of hepatic lipase deficiency

A natural deficiency of hepatic lipase in rabbits has been exploited to gain insights into the physiological role of this enzyme in the metabolism of plasma lipoproteins. A comparison of human and rabbit lipoproteins revealed obvious species differences in both low-density lipoproteins (LDL) and high-density lipoproteins (HDL), with the rabbit lipoproteins being relatively enlarged, enriched in triacylglycerol and depleted of cholesteryl ester. To test whether these differences related to the low level of hepatic lipase in rabbits, whole plasma or the total lipoprotein fraction from rabbits was either kept at 4 degrees C or incubated at 37 degrees C for 7 h in (i) the absence of lipase, (ii) the presence of hepatic lipase and (iii) the presence of lipoprotein lipase. Following incubation, the lipoproteins were recovered and subjected to gel permeation chromatography to determine the distribution of lipoprotein components across the entire lipoprotein spectrum. An aliquot of the lipoproteins was subjected also to gradient gel electrophoresis to determine the particle size distribution of the LDL and HDL. Both hepatic lipase and lipoprotein lipase hydrolysed lipoprotein triacylglycerol and to a much lesser extent, also phospholipid. There were, however, obvious differences between the enzymes in terms of substrate specificity. In incubations containing hepatic lipase, there was a preferential hydrolysis of HDL triacylglycerol and a lesser hydrolysis of VLDL triacylglycerol. By contrast, lipoprotein lipase acted primarily on VLDL triacylglycerol. When more enzyme was added, both lipases also acted on LDL triacylglycerol, but in no experiment did lipoprotein lipase hydrolyse the triacylglycerol in HDL. Coincident with the hepatic lipase-induced hydrolysis of LDL and HDL triacylglycerol, there were marked reductions in the particle size of both lipoprotein fractions, which were now comparable to those of human LDL and HDL3, respectively.     

Induction and evaluation of atherosclerosis in New Zealand white rabbits

Atherosclerosis was experimentally induced in New Zealand white rabbits by feeding a high cholesterol diet for 12 weeks for screening of drugs against atherosclerosis. After 12 weeks, blood was collected from ear vein for evaluation of total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, then the animals were sacrificed to collect the livers for estimation of cholesterol, and aorta for gross and histopathological evaluations. The elevated levels of serum and liver parameters accompanied by gross and histopathological changes like accumulation of foam cells, atheromatous plaque formation and replacement fibrosis supported the successful induction of atherosclerosis in New Zealand white rabbits.     

Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver

Monoclonal antibodies that bound to the external domain of the rabbit low density lipoprotein receptor-related protein (LRP) were taken into rabbit fibroblasts by receptor-mediated endocytosis. Uptake occurred in fibroblasts from Watanabe-heritable hyperlipidemic rabbits, which lack low density lipoprotein receptors, as well as in normal rabbit fibroblasts. The fate of the internalized antibodies differed, depending on the domain of LRP that was recognized. LRP is synthesized as a single polypeptide chain that is cleaved to form a heterodimer of two noncovalently bound proteins, 1) a 515-kDa subunit that contains the binding domain, and 2) an 85-kDa subunit that contains the membrane-spanning region and cytoplasmic tail. A monoclonal antibody directed against the 515-kDa subunit (anti-LRP 515) rapidly dissociated from LRP at pH 5.2. After uptake by cells this antibody dissociated from the receptor and was degraded in lysosomes. A second antibody directed against the external portion of the 85-kDa subunit (anti-LRP 85) failed to dissociate at acid pH. After uptake by cells this antibody was not degraded, but instead was released from the cells in an acid-precipitable form. When administered intravenously to rabbits, both 125I-labeled antibodies were rapidly cleared from the circulation, 75-95% of the uptake occurring in the liver. The anti-LRP 515 antibody was degraded and acid-soluble products appeared in the plasma. No significant acid-soluble products appeared when the anti-LRP-85 antibody was infused. We conclude that LRP can carry out receptor-mediated endocytosis and that its ligand-binding domain, like the similar domain of the low density lipoprotein receptor, undergoes an acid-dependent conformational change that ejects ligands within the endosome. We also conclude that in the body this endocytotic function is expressed primarily in the liver. Both of these conclusions lend support to the hypothesis that LRP may function in humans and animals as a receptor for apolipoprotein E-enriched lipoproteins, such as chylomicron remnants.